AMPH: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net revenues	536,782	-
Payroll expense	143,233	-
Materials and supplies	29,344	-
Clinical trials expense	1,489	-
Depreciation and amortization expense	42,354	-
Stock-based compensation expense	21,072	-
Consulting and outside services expense	27,772	-
Advertising & promotional expense	10,349	-
Other segment items	156,864	-
Interest income	6,256	-
Interest expense	18,851	-
Income tax provision	18,045	-
Net income	73,665	56,315
Loss on disposal of assets	-33	-32
Loss (gain) on interest rate swaps and foreign currency transactions, net	-2,021	-1,736
Depreciation of property, plant, and equipment	23,576	15,716
Amortization of intangible assets	18,778	12,509
Operating lease right-of-use asset amortization	4,860	3,221
Amortization of discounts, premiums, and debt issuance costs	2,489	1,604
Share-based compensation expense	21,072	14,775
Accounts receivable, net	9,599	-4,192
Inventories	30,072	35,932
Prepaid expenses and other assets	13,358	5,417
Income tax refunds, deposits, and payable, net	4,345	8,467
Operating lease liabilities	-3,953	-2,362
Accounts payable and accrued liabilities	38,085	12,747
Net cash provided by operating activities	123,252	70,669
Purchases and construction of property, plant, and equipment	26,610	21,262
Purchase of intangible assets	2,250	2,250
Purchase of investments	50,825	15,619
Maturity of investments	73,849	51,322
Deposits and other assets	3,927	2,335
Net cash used in investing activities	-9,763	9,856
Proceeds from equity plans, net of withholding tax payments	873	494
Purchase of treasury stock	55,070	50,220
Debt issuance costs	679	675
Proceeds from borrowing under lines of credit	5,943	5,771
Principal payments on long-term debt	119	75
Net cash provided by (used in) financing activities	-49,052	-44,705
Effect of exchange rate changes on cash	219	260
Net increase (decrease) in cash, cash equivalents, and restricted cash	64,656	36,080
Cash and cash equivalents at beginning of period	151,844	-
Cash and cash equivalents at end of period	216,500	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

AMPH: the cashflow